News and Events

2023-02-03 ·Medicilon Events

Medicilon won the "2022 Science and Technology Innovation Contribution Award" in Baoshan District, Shanghai

On January 28, 2023, the joy and excitement of the New Year still linger in the hearts. Shanghai Medicilon Inc. (Medicilon) had a good start and good news to share. Medicilon subsidiary, Medicilon (Baoshan) Inc. (Medicilon Baoshan) won the "2022 Science and Technology Innovation Contribution Award" in Baoshan District, Shanghai.

2023-02-03 ·Medicilon Events

Medicilon 19th Anniversary

Medicilon welcome the year of 2023 and also welcome the 20th year of success. 19 years of overcoming obstacles, 19 years of non-stop innovation and 19 years of R&D acceleration, Medicilon, as a professional biopharmaceutical preclinical comprehensive R&D service CRO, covers the entire process of preclinical new drug research such as drug discovery, pharmaceutical research and preclinical research, in addition of expanding the CDMO service and the global development.

2023-01-06 ·Medicilon Events

Medicilon Cell & Gene Therapy Drug R&D Service Platform

Medicilon's preclinical research services cover pharmacodynamic research, drug safety evaluation, pharmacokinetic research, bioanalysis, etc. The establishment of a complete gene therapy R&D platform can provide one-stop services for research on pharmacological efficacy, biodistribution and safety evaluation of cell and gene therapy products.

2023-01-06 ·Medicilon Events

2022 Memories | Medicilon Is For You

Looking back at Medicilon 2022, even the most extraordinary days never stop moving forward. Because there is always light guiding us to move forward; there is always love, shining for a long time. Thank you for the moments and memories that link us together. This accumulates as the strength to forge ahead in the New Year.

2022-12-28 ·Medicilon Events

Medicilon participated in the annual meeting of the American Chinese Biomedical Technology Association on Christmas Eve

The 27th Annual Chinese Biopharmaceutical Association (CBA) Meeting will be held on December 17, 2022, at the Marriott Washingtonian Center in Maryland!

2022-12-28 ·Medicilon Events

Listed for 3 consecutive years! Medicilon won the "Top 20 Chinese R&D CRO Enterprises in 2022"

Shanghai Medicilon Inc. (Medicilon), as a one-stop pharmaceutical preclinical R&D service platform in China, was once again selected as one of the "Top 20 Chinese R&D CRO Enterprises in 2022" by virtue of its solid R&D strength. This is the 3rd consecutive year that Medicilon has won this honorary title!

2022-12-28 ·Medicilon Events

Translational Medicine - Accelerate the R&D process of innovative drugs and precision medicine

The Medicilon translational medicine platform has an experienced professional technical team, starting from the mechanism of action of drug targets and the clinical application of biomarkers, based on the discovery and validation of biomarkers, combining a variety of different technology platforms and state-of-art instruments, and creating multiple bioanalytical methods, to reduce the cost and time of drug R&D, and provide diverse and efficient services for different types of drugs, different kinds of pharmaceutical companies and projects at different R&D stages.

2022-12-22 ·Medicilon Events

Medicilon wish you a merry christmas

Christmas is coming up! Wishing you all the Hope, Wonder, and Joy! Have a delicious time!

2022-12-09 ·Medicilon Events

Holiday Promotion: Medicilon Antibody Development Technology Service with Discount Price

Medicilon Antibody Development Technical Service is here to help you develop new drugs with high cost performance, high efficiency and high quality.